Table 2.
Description of the exercise intervention programs of the studies included in the systematic review
| Author | Exercise intervention | Progression | Recruitment / adherence rate | Safety | Dropouts |
|---|---|---|---|---|---|
| During anticancer treatment | |||||
| Rogers L.Q. et al. (2013) | 6 weeks supervised + 6 weeks unsupervised resistance training, twice a week, 9 exercises vs. usual care | Yes |
RR: 45.0% AR: 83% (supervised); 62% (unsupervised) |
CG: non-EX related left arm pain (non-serious); hospital admission for narcotic-related dehydration and constipation (serious); IG: non-EX related hospital admission for infectious diarrhea | IG:28,6%; CG:0% |
| Samuel S.R. et al. (2013) | 11 weeks of supervised aerobic training 15/20 min per session at 3–5 RPE + resistance training, 2–3 sets of 8–15 reps at 3–5 RPE, 5 days per week vs. usual care | NR |
RR: 92.3% AR:NR |
No | IG:16,7%; CG: 4,2% |
| Capozzi L.C. et al. (2016) | 12 weeks of supervised and unsupervised resistance training four times per week (twice supervised + twice home-based), 10 exercises, 2–3 sets for 8 reps vs. usual care | Yes |
RR: 55.6% AR: 45.2% |
NR | IG:38.7%; CG:20.7% |
| Zhao S.G. et al. (2016) | 7 weeks of supervised + 7 weeks of unsupervised walking training + resistance training of 3 sets of 8–12 reps at 11–13 RPE, thrice a week for the supervised period, five times per week during the unsupervised period vs. usual care | NR |
RR: NR AR: 72.0% |
NR | IG:0.0%; CG:22.2% |
| Grote M. et al. (2018) | 7 weeks of supervised resistance training thrice a week, 3 exercises, 3 sets of 8–12 reps vs. usual care | Yes |
RR: 20.0% AR: 90.0% |
non-EX related pain (for mucositis)/ abdominal tension (for endoscopic gastrostomy) | NR |
| Samuel S.R. et al. (2018) | 7 weeks of supervised + 6 weeks unsupervised aerobic training 15/20 min per session at 3–5 RPE + resistance training, 1 set of 8–15 reps at 3–5 RPE, 5 days per week vs. usual care | NR |
RR:60.2% AR:NR |
NR | IG: 21,6%; CG: 10.8% |
| Yen C.J. et al. (2019) | 8 weeks of aerobic training, 30 min per session at 60/70% HRmax + resistance training, 10 exercises, 2 sets of 10 repetition at 3–5 RPE vs. usual care | NR |
RR: NR AR: NR |
NR | IG: 19.1%; CG: 9.5% |
| Lin K.Y. et al. (2021) | 8 weeks of supervised aerobic training, 30 min per session at 60/80% of HRmax + moderate/hard resistance training, 1–3 sets of 8–12 reps, thrice a week vs. usual care | Yes |
RR: 60.6% AR: 93.1% |
NR | IG: 31%; CG:28,6% |
| After anticancer treatment | |||||
| Lønbro S. et al. (2013) | 12 weeks of supervised and unsupervised resistance training, 2.5 times per week, 7 exercises, 2–3sets of 8–15 reps vs. waiting list | NR |
RR:22% AR: 91% |
No adverse events were registered | IG: 5%; CG: 19% |
NR not reported, RR recruitment rate, AR adherence rate, IG interventional group, CG control group, BMI body mass index, 6MWT 6-min walking test, QoL quality of life. The arrow up (↑) symbol denotes significant improvement; the arrow down (↓) symbol denotes significant worsening; the double head arrow ν(↔) denotes no significant change